5-Azacytidine is a potent and commonly studied anticancer agent that has gained traction in modern research due to its strong therapeutic potential in a variety of cancer types. In this article, we will dive deep into the chemical, pharmacological, and biological properties of 5-Azacytidine (CAS: 320-67-2) to explore its health benefits, potential effects, and safety concerns.
Introduction: 5-Azacytidine is a well-known chemical compound that has emerged as a potent anticancer agent in recent years. It is a pyrimidine nucleoside analog with the chemical name 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one. Its molecular formula is C8H12N4O5, and it has a molecular weight of 244.21 g/mol. 5-Azacytidine is an analog of cytidine with the nitrogen atom at position 5 replacing the carbon atom. This substitution results in the inhibition of DNA methyltransferases, leading to changes in gene expression and cell differentiation.
CAS No: 320-67-2
Top Ten Keywords from Google and Synonyms:
Synonyms:
Health Benefits of this Product: 5-Azacytidine has been found to be an effective therapy for a variety of cancer types, including acute myeloid leukemia, myelodysplastic syndrome, and chronic myelomonocytic leukemia. It is also used in the treatment of Hodgkin's lymphoma, non-Hodgkin's lymphoma, and solid tumors such as lung, ovarian, and breast cancer. Additionally, it has shown promise in the treatment of sickle cell anemia.
Potential Effects: The primary mechanism of action of 5-Azacytidine is through its inhibition of DNA methyltransferases. DNA methylation is a process in which a methyl group is added to the DNA molecule, resulting in the restriction of gene expression. By inhibiting this process, 5-Azacytidine prevents the restriction of gene expression and promotes cell differentiation, leading to the death of cancer cells. It has also been shown to activate tumor suppressor genes and induce apoptosis in cancer cells.
Product Mechanism: 5-Azacytidine enters the cell and is phosphorylated to its active metabolite, 5-azadeoxycytidine triphosphate, which is then incorporated into DNA during replication. The incorporation of this metabolite leads to DNA hypomethylation, resulting in the activation of tumor suppressor genes and the inhibition of oncogenic pathways.
Safety: 5-Azacytidine is generally well-tolerated, but like any medication, it can cause side effects. Mild side effects include nausea, vomiting, and fatigue. More severe side effects may include blood disorders, myelosuppression, and myelotoxicity. It should not be used in patients with renal or hepatic impairment or in pregnant or breastfeeding women.
Side Effects: Common side effects of 5-Azacytidine include nausea, vomiting, fatigue, and constipation. More severe side effects may include anemia, thrombocytopenia, neutropenia, and myelosuppression. Other potential side effects may include fever, chills, infections, bleeding, and shortness of breath.
Dosing Information: The recommended dosage of 5-Azacytidine for cancer patients is 75 mg/m2/day for seven days, administered subcutaneously or intravenously. Treatment is administered in cycles of 28 days, with a maximum of six cycles recommended.
Conclusion: 5-Azacytidine is a potent and effective anticancer agent that has shown promise in the treatment of a variety of cancer types. Its primary mechanism of action is through the inhibition of DNA methyltransferases, leading to changes in gene expression and cell differentiation. However, it is not without its risks and potential side effects, and it should be used with caution in patients with underlying medical conditions. Despite its potential side effects, 5-Azacytidine remains an essential drug in the fight against cancer, and its continued research and development hold significant promise for the future of cancer therapy.
